Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus in Relapsed/Refractory Hodgkin's Lymphoma
NCT00838955Phase 2Terminated
- Sponsor
- Loyola University Chicago
- Start
- Jan 2009
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temsirolimus in Hodgkin lymphoma (HL), sponsored by Loyola University Chicago. Started Jan 2009; status: terminated.
02
Drugs
temsirolimus
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00838955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00838955.